LENZ Therapeutics announced topline results from its Phase 3 CLARITY clinical trials of aceclidine for the treatment of presbyopia and will host a conference call and webcast to discuss the results.
AI Assistant
LENZ THERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.